News About: Pharm. Industry
Pfizer Korea recorded KRW 628.3 billion sales yet spent KRW 1.7 billion on donationsIt is observed that although a multinational pharmaceutical company, Pfizer Korea, recorded KRW 628.3 billion sales last year, it only spent approximately KRW 1.7 billion on don...
|
Pharmaceutical associations are pushing forward with the CP Academy, stating “We are firm in ethical management”
“We are firm in a will to settle ethical management as early as possible.”
The pharmaceutical industry has paid attention on the fact that 2 pharmaceutical associations agreed to hold a so-called CP(Compliance Progra...
Is it because of the tightened CP? Multinational pharmaceutical companies are actively investing in advertisements
A series of new advertisements of multinational pharmaceutical companies’ major products has been out.
According to the industry concerned on the 13th, pharmaceutical companies, such as Menarini, Bayer, Sanofi, Kowa ...
The arrest warrant for CEO of IMS Health Korea is withdrawn “The influence of a criminal trial will be minor”The arrest warrant for CEO of IMS Health Korea, a medical consulting company suspicious of collecting and selling medical records of patients, has been withdrawn.
According to ...
|
President Kyung-ho Lee of the KPMA stated “We put everything on eradication of illegal rebates”
The Korea Pharmaceutical Manufacturers Association (KPMA) has put everything on eradication of illegal rebates. It expressed an opinion to get rid of disgrace of the ‘pharmaceutical=rebate’ industry even with any obst...
IMS Health stated “Sales of patients’ personal information is not true”
IMS Health expressed that the press reported ‘IMS’s sales of personal information to its headquarters’, but it is not true.
“IMS Health is a global company providing syndicate market research services related to heal...
The obesity association with positive feelings, stating “Effective obesity treatments have emerged”
“Obesity was a disease that doctors have trouble to treat with, accompanying various associated diseases, but I feel encouraged by the recent emergence of many effective drugs as a doctor.”
This is what an endocrinol...
Johnson & Johnson made controversy through the pharmacists’ antismoking counseling campaign
Controversy is expected as Johnson & Johnson Korea, selling the antismoking supplement ‘Nicorett’, has contracted a partnership with the Korean Pharmaceutical Association, making a campaign saying ‘Pharmacies will hel...
Caduet, the ARB+Statin drug, keeps its indisputable position at the top while Hanmi and Daewoong are chasing
It is known that Pfizer’s Caduet has kept its position at the top in the ARB+Statin drug market, representing hypertension+hyperlipidemia complexes. Then, it is followed by other last movers, such as Hanmi Pharm and D...
Roche Korea spent KRW 7.9 billion to reconstruct almost 20 employees at the end of the last year
It is observed that a Swiss multinational pharmaceutical company, Roche Korea, spent almost KRW 8 billion as ERP (Early Retirement Plan) expenses for a part of its employees.
Roche Korea unveiled through an audit rep...
